Pfizer-BioNTech says its COVID-19 vaccine safe, effective in kids aged 5-11

Pfizer and BioNTech say their COVID-19 vaccine induced a robust immune response in five- to 11-year-olds. They plan to seek approval to use the vaccine in children in that age range in the U.S., Europe and elsewhere as soon as possible.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting